U.S. Video

Apple Pay getting hit by rivals     Mon, 27 Oct '14 | 9:00 AM ET

Just a week old, rivals are popping up and threatening the success of Apple Pay.

CNBC's Jim Cramer and David Faber discuss Goldman Sachs' downgrade of its oil forecast. Cramer explains why he disputes the call.

Pharma fight: What's Allergan worth?     Mon, 27 Oct '14 | 9:08 AM ET

CNBC's David Faber reports Valeant Pharmaceuticals is willing to increase its bid for Allergan to at least $200 a share. Jim Cramer provides insight to litigation against investor Bill Ackman over insider trading

Cramer's stock to watch: Allergan     Mon, 27 Oct '14 | 8:53 AM ET

CNBC's Jim Cramer is watching shares of Allergan, Brazil's stock market and earnings this week.

Geoff Dennis, UBS, shares his thoughts on how President Dilma Rousseff's win will likely impact Brazil's markets.

Melissa Etheridge goes mobile     Mon, 27 Oct '14 | 8:42 AM ET

CNBC's Jane Wells reports Melissa Etheridge is experimenting to see if mobile games can be a new way to distribute music.

Twitter's path to 'tweet' success     Mon, 27 Oct '14 | 8:35 AM ET

Now's a unique opportunity to buy the stock, says Neil Doshi, CRT Capital Group, providing his read on Twitter. Shares are up more than 80% since going public.

CNBC's Meg Tirrell reports NBC News has confirmed a pediatric patient was taken overnight to Bellevue Hospital in New York City with symptoms similar to Ebola.

Check out deer window shopping     Mon, 27 Oct '14 | 8:25 AM ET

A buck crashed through a furniture store's grand opening in Cedar Falls, Iowa but apparently didn't find anything he liked.

Apple Pay problems     Mon, 27 Oct '14 | 8:29 AM ET
Apple Pay on display.

Apple's new mobile payment system is coming under fire from some retailers and competitors, reports CNBC's Mary Thompson.

Checkup on big pharma     Mon, 27 Oct '14 | 8:15 AM ET

Barbara Ryan, FTI Consulting, breaks down the numbers on Merck's quarterly results as the company appears to be reaping the rewards of R&D. Also a look ahead to Pfizer's earnings

While Fundstrat's Thomas Lee and Deutsche Bank's David Bianco agree on the direction of the market, they were at odds, in a CNBC interview, over the impact of falling oil prices.

Tempted by Apple     Mon, 27 Oct '14 | 8:05 AM ET

Kevin Landis, Firsthand Capital Management, shares his thoughts on Apple's valuation. It's the ultimate growth at a reasonable price stock, says Landis.

Titans of tech: Twitter, IBM & Amazon     Mon, 27 Oct '14 | 8:05 AM ET

Kevin Landis, Firsthand Capital Management, discusses the outlook on Twitter, IBM's growth story and Amazon's price war.

I could kick myself over Netflix     Mon, 27 Oct '14 | 8:05 AM ET

Kevin Landis, Firsthand Capital Management, discusses his optimistic outlook on Netflix. Look at this great position they've got, says Landis.

What viewers want     Mon, 27 Oct '14 | 7:43 AM ET

Richard Greenfield, BTIG, weighs in on consolidation in the media sector and the prospects of an unbundled world.

'Dead' money on Wall Street?     Mon, 27 Oct '14 | 7:43 AM ET

Richard Greenfield, BTIG, shares his thoughts on why AMC's record-setting "Walking Dead" series is not rewarding its stock.

Crude oil flirts with $80 level     Mon, 27 Oct '14 | 7:33 AM ET

Matt Smith, Schneider Electric, breaks down the play in the energy complex. And Boris Schlossberg, BK Asset Management, provides his take on German confidence.

Dr. Craig Spencer is at Bellevue Hospital in New York undergoing treatment for Ebola.

CNBC's Meg Tirrell reports the latest details on the condition of Dr. Craig Spencer and the controversy about travel bans and quarantines.

Thomas Lee, Fundstrat Global Advisors, and David Bianco, Deutsche Bank, weigh in on catalysts investors should be watching this week.

The FDA wants more data on the new drug, reports CNBC's Meg Tirrell with the latest details.

Monday morning quarterback     Mon, 27 Oct '14 | 6:52 AM ET

The "Squawk Box" news team and Dave Briggs, NBC Sports, discuss this year's World Series playoff, and week 8 in the NFL.

Key midterm elections to watch     Mon, 27 Oct '14 | 6:36 AM ET

CNBC's John Harwood provides a preview of the upcoming elections. Democrats are holding tough but Republicans have the advantage, reports Harwood.

Markets focus on Fed's taper timeline     Mon, 27 Oct '14 | 6:13 AM ET
Federal Reserve Board Chair Janet Yellen

Lou Brien, DRW Trading, and Michelle Meyer, Bank of America Merrill, share their thoughts on what to expect from this week's FOMC meeting, and the market's likely reaction to the Fed's exit plan for QE.

European banks stress test results     Mon, 27 Oct '14 | 6:09 AM ET
A euro logo next to the headquarters of the European Central Bank in Frankfurt.

Martin Wolf, Financial Times, provides insight to the strength of European banks.

Earnings, Fed in focus for stocks     Mon, 27 Oct '14 | 5:58 AM ET

Following the best week of the year for stocks, the major indexes have a shot at wiping out the once-heavy October losses during the month¿s final week.

Entitlement attitude     Sat, 25 Oct '14 | 9:05 PM ET

How your attitude about what you're entitled to can derail your financial future.

1-on-One: Suze house call     Sat, 25 Oct '14 | 9:04 PM ET

Tony and Joanna ask Suze if they should save for tomorrow or live for today. They want to retire sooner rather than later.

Can I Afford It? Mike     Sat, 25 Oct '14 | 9:03 PM ET

Mike, who's 40, says he wants to give his fiancée the wedding of her dreams. He asks Suze if he can afford to spend $50,000 to do it.

How Am I Doing? Joe     Sat, 25 Oct '14 | 9:01 PM ET

Joe, who's 52, single and living in New York, asks Suze if he's on track to retire at 67 and move to Italy, where he has dual citizenship.

CNBC TV Worldwide

  • The reality series features the sharks who give budding entrepreneurs the chance to make their dreams come true.

  • “Restaurant Startup” is on a quest to discover, invest in and launch America's next generation of epicurean superstars.

  • CNBC's "American Greed" examines the dark side of the American dream. Some people will do anything for money!